ZYDUSLIFE Zydus Lifesciences Ltd Company Mergers Announcement 2025 - Biologics Acquisition Zydus Lifesciences Ltd plans to acquire biologics manufacturing facilities in California from Agenus for $75 million, with potential additional payments of up to $50 million over three years, enhancing its capabilities in the global biologics sector. The acquisition is set to significantly expand Zydus's operations in the U.S. and globally, with a focus on manufacturing immuno-oncology products..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Zydus Lifesciences Ltd